Thromboprophylaxis with apixaban and the risk of pulmonary embolism in patients undergoing knee replacement surgery

BACKGROUND: Apixaban, a novel oral anticoagulant, is also used for deep vein thrombosis (DVT) prophylaxis. In this study, we sought to critically evaluate the differences in the rates of symptomatic DVT and bleeding, and analyze the rates of pulmonary embolism (PE) in subgroups of patients from ADVA...

Descripción completa

Detalles Bibliográficos
Autores principales: Aryal, Madan Raj, Pandit, Anil, Ghimire, Sushil, Pathak, Ranjan, Karmacharya, Paras, Poudel, Dilli Ram, Shamoun, Fadi E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Co-Action Publishing 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558285/
https://www.ncbi.nlm.nih.gov/pubmed/26333856
http://dx.doi.org/10.3402/jchimp.v5.27889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558285/
https://www.ncbi.nlm.nih.gov/pubmed/26333856
http://dx.doi.org/10.3402/jchimp.v5.27889

Ejemplares similares